Esperion Therapeutics Inc.

NASDAQ: ESPR
Share price (1/6/25): $2.15
Market cap (1/6/25): $424 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Halladay Benjamin

Koenig Sheldon L.

Koenig Sheldon L.

News Filter

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Announces $210 Million Convertible Debt Financing

U.S. Net Product Revenue of $31.1 Million, Representing 53% Growth –

Reports Second Quarter 2024 Financial Results and Provides a Business Update

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC